Skip to main content

Verónica Villagrasa Araya

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Verónica Villagrasa Araya

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Miriam Calles Bastande

Miriam Calles Bastande

Read more
Jordi Canals Serrat

Jordi Canals Serrat

Research technician
Shock, Organ Dysfunction and Resuscitation
Read more
Paula Capilla Fernández

Paula Capilla Fernández

Purchase and Biddings Unit
Finance Directorate
Read more
Roberto Orsenigo

Roberto Orsenigo

Predoctoral researcher
Biomedical Research in Melanoma
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.